According to Benzinga Pro, Stifel Financial's peer group average for short interest as a percentage of float is 3.25%, which ...

Vistagen Therapeutics, Inc. (NASDAQ:VTGN) is among the best growth stocks to invest in for the next 5 years. Analysts at ...

Host Hotels & Resorts, Inc. (NASDAQ:HST) is one of the most undervalued stocks. On June 5, Stifel maintained a Buy rating on ...

Vistagen Therapeutics, Inc. (NASDAQ:VTGN) is among the best growth stocks to invest in for the next 5 years. Analysts at Stifel reiterated their Buy rating on Vistagen Therapeutics, Inc. (NASDAQ ...

Leidos Holdings, Inc. (NYSE:LDOS) is one of the 10 undervalued tech stocks flying under Wall Street’s radar. On June 23, Stifel Nicolaus issued a “Buy” rating for Leidos after resuming ...

Stifel upgrades Oracle to 'Buy' with a $250 target, citing sustainable cloud growth and efficient spending. Analyst Brad ...

Oracle (NYSE:ORCL) shares rose more than 4.5% on Monday after CEO Safra Catz touted a “strong start” to fiscal 2026 and investment firm Stifel upgraded the IT giant. “Oracle is off to a ...

Investing.com - Stifel has increased its price target on IDEXX Laboratories (NASDAQ: IDXX) to $540.00 from $510.00 while maintaining a Hold rating on the stock. Currently trading at $542.65, IDEXX ...

Stifel analysts have adjusted their outlook on Eos Energy by lowering the stock’s price target to $8.50 while maintaining a Buy rating, citing a stronger balance sheet despite recent stock dilution.

The pivotal trial for Neurogene's Rett syndrome gene therapy makes use of baseline controls and a rigorous endpoint that ...

Oracle shares surged to an all-time high Monday as CEO Safra Catz touted a “strong start” to fiscal 2026 for the tech giant, ...